ORLANDO, Fla., March 15, 2012 /PRNewswire/ -- Waters
Corporation (WAT: NYSE) was today awarded the prestigious 2012
Pittcon Editors' Gold Award for the new Waters® ACQUITY UPC(2)™
System as the best new product at the 2012 Pittsburgh Conference on
Analytical Chemistry and Applied Spectroscopy.
(Logo:
http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)
Employing the principle of UltraPerformance Convergence
Chromatography™ (UPC(2)), ACQUITY UPC(2) System expands the
boundaries of reverse phase liquid chromatography (LC) and of gas
chromatography (GC) separations and offers a replacement option for
normal phase chromatography. ACQUITY UPC(2) provides
scientists with an indispensable new tool for tackling
tough-to-analyze compounds including hydrophobic and chiral
compounds, lipids, thermally-labile samples and polymers across a
wide range of applications.
"On behalf of all Waters employees worldwide, we graciously
thank the Pittcon Editors for recognizing the new ACQUITY UPC(2)
System and its promise as a new category of separation science,"
said Art Caputo, President of the
Waters Division. "Since its founding 61 years ago, Pittcon
has been one of the most important annual conferences where
scientists can learn about the newest developments in laboratory
science that can help them speed discovery, uncover new truths, and
further the advancement of science. In 2004, the Pittcon
Editors selected the ACQUITY UltraPerformance LC® (UPLC®) to
receive their gold award for best in show. Since then,
thousands of ACQUITY UPLC systems have been adopted by leading
laboratories around the world changing the landscape and impact of
chromatography. We believe that ACQUITY UltraPerformance
Convergence Chromatography holds that same potential by bridging
the gap between LC and GC technologies -- apparently leading
scientific editors agree."
Harnessing Compressed CO2 Broadens Separations
Options
Compressed carbon dioxide (CO2), the primary mobile phase for
ACQUITY UPC(2), offers numerous major advantages over liquid mobile
phases or carrier gases that are used with LC and GC. For one, CO2
alone, or in combination with a co-solvent, is a low viscosity
mobile phase that achieves higher diffusion rates and enhanced mass
transfer than liquids used in HPLC. For another, when compared to
GC, CO2 alone is a mobile phase that allows separations to occur at
a much lower temperature. Scientists can routinely separate
compounds that are less amenable to analysis by LC and GC including
molecules having a wide range of polarities.
Along with industry leading sub two-micron particle column
chemistries, ACQUITY UPC(2) System gives scientists the ability to
precisely vary mobile phase strength, pressure, and temperature.
With this ability to fine-tune the resolving power and selectivity
of the system, scientists can exercise better control over the
retention of analytes for separating, detecting and quantifying
structural analogs, isomers, and enantiomeric and diasteriomeric
mixtures – all compounds that are often difficult to separate by
any other means. A key benefit of the ACQUITY UPC(2) System is the
use of inexpensive and non-toxic compressed CO2 as a primary mobile
phase that can take the place of toxic and volatile organic
solvents that are extremely expensive to purchase and dispose.
The ACQUITY UPC(2) System is a product of Waters' extensive
history of quality instrument design and development experience and
exhibits Waters' trademark ruggedness, reliability and ease-of-use.
Its key features include:
- A 10 microliter fixed loop injector for partial loop injections
of between 0.5 microliters and 10 microliters preserves sample and
eliminates the need to change sample loops.
- Reduced system volume enables shorter run times, optimizes
gradient performance, reduces band broadening, and enables the use
of small particle size columns.
- Co-solvent and column switching for more flexible methods
development, faster solvent and column screening.
- Gradient accuracy and precision assures retention time
reproducibility.
- Improved optical detection and MS compatibility for conducting
qualitative and quantitative analyses.
Waters ACQUITY UPC(2) System is the perfect complement to MS due
to its low solvent load, exceptional resolving power, narrow peaks
and fast separations. Whether analyzing natural products,
traditional medicines, drugs, food additives or contaminants,
pesticides, surfactants, polymer additives, lipids, or biofuels,
Waters ACQUITY UPC(2) System delivers unparalleled separations and
peak shape. Like all of Waters ACQUITY-based products, ACQUITY
UPC(2) System maximizes the benefits of Waters chemistries like the
new ACQUITY UPC(2) System as well as industry-leading informatics
software and expert support.
The ACQUITY UPC(2) System now takes its place alongside LC and
GC as a powerful complementary technique for taking on the
laboratory's toughest separations challenges
For more information: http://www.waters.com/upc2
About Waters Corporation (www.waters.com)
For over 50 years, Waters Corporation (NYSE: WAT) has created
business advantages for laboratory-dependent organizations by
delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery,
environmental management, food safety, and water quality
worldwide.
Pioneering a connected portfolio of separations science,
laboratory information management, mass spectrometry and thermal
analysis, Waters technology breakthroughs and laboratory solutions
provide an enduring platform for customer success.
With revenue of $1.85 billion in
2011, Waters is driving scientific discovery and operational
excellence for customers worldwide.
Waters, UPC(2), UltraPerformance Convergence Chromatography,
ACQUITY, and UPLC are trademarks of Waters Corporation.
SOURCE Waters Corporation